ARMI | BioFabUSA will attend Meeting on the Mesa 2025, one of the premier partnering events for the cell and gene therapy sector, taking place October 6–8 in Phoenix, AZ. […]
Hosted by the BioFab Startup Lab, the 2025 BioFab Investment Summit connects early-stage companies with investors and partners driving regenerative medicine forward.
ARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
BioFabUSA will exhibit and present at DMC 2025, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
